Apollo Hospitals Enterprise Limited has received in-principle approval from the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for issuing and allotting a maximum of 21,56,770 equity shares under its Employee Stock Option Plan 2024. These shares, valued at Rs. 5/- each, will be offered to eligible employees of the company, reinforcing its commitment to employee welfare.
ESOP Approval Granted
Apollo Hospitals Enterprise Limited announced that it has secured in-principle approval from both the BSE and NSE for its Employee Stock Option Plan (ESOP) 2024. This approval allows the company to proceed with issuing and allotting shares to its employees under the terms of the plan.
Details of the ESOP
The approval covers a maximum of 21,56,770 equity shares, each with a face value of Rs. 5/-. These shares are intended to be allotted to the company’s employees as part of the Apollo Hospitals Enterprise Limited Employee Stock Option Plan 2024 (Apollo ESOP 2024).
Official Communication
The company officially communicated that the approval letters from BSE (reference number DCS/ESOP/IP/TS/3877/2025-26) and NSE (reference number NSE/LIST/51179), both dated November 7, 2025, have been received. These approvals mark a significant step forward in the implementation of the ESOP, allowing the company to reward and incentivize its employees through equity participation.
Source: BSE
